Clinical Trial Update: Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I [Phase 1]

View source ↗

Summary

Phase I clinical trial of Ziv-aflibercept for retinal diseases, including age-related macular degeneration and central retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Central Retinal Vein Occlusion

Drugs mentioned

• Ziv-aflibercept (ziv-aflibercept)

Snippet

Sponsor: Rafic Hariri University Hospital | Conditions: Age Related Macular Degeneration, Central Retinal Vein Occlusion | Phase 1 | Status: UNKNOWN